mTOR inhibitors in castration-resistant prostate cancer: a systematic review

CM Statz, SE Patterson, SM Mockus - Targeted oncology, 2017 - Springer
Background The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …
被引用次数：68 相关文章

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review

CM Statz, SE Patterson, SM Mockus - Targeted Oncology, 2017 - hero.epa.gov
BACKGROUND: The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.

CM Statz, SE Patterson, S Mockus - 2017 - mouseion.jax.org
BACKGROUND: The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review

CM Statz, SE Patterson, SM Mockus - Targeted Oncology, 2016 - infona.pl
Background The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review

CM Statz, SE Patterson, SM Mockus - Targeted Oncology, 2017 - search.proquest.com
Background The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review

CM Statz, SE Patterson, SM Mockus - Targeted oncology, 2017 - pubmed.ncbi.nlm.nih.gov
Background The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.

CM Statz, SE Patterson, SM Mockus - Targeted Oncology, 2017 - europepmc.org
Background The progression of prostate cancer to castration-resistant prostate cancer
(CRPC) is often a result of somatic alterations in the PI3K/Akt/mTOR (mammalian target of …